GeneDx
WGS
NASDAQ
IPO2021
about WGS
GeneDx provides comprehensive genetic testing solutions to identify inherited diseases, cancer predispositions, and other medical conditions, helping guide clinical diagnosis and personalized treatment plans for patients.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $162.72 | $162.89 | $156.00 | $4.59B | 476.17K |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.27 | n/a | 38.85 | -2.78% | -6.54% | 0% |